Spruce Biosciences, Inc. (SPRB) vs Tonix Pharmaceuticals Holding Corp. (TNXP)
A side-by-side comparison of Spruce Biosciences, Inc. and Tonix Pharmaceuticals Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SPRB
Spruce Biosciences, Inc.
$42.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TNXP
Tonix Pharmaceuticals Holding Corp.
$7.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SPRB vs TNXP
growth of $100 · dividends reinvested · last 6ySPRB -96.4% (-42.6%/yr)TNXP -100.0% (-83.3%/yr)SPRB compounded faster over this window
Log scale — wide-divergence pair
SPRB TNXP
SPRB vs TNXP: by the numbers
- •TNXP is the larger company ($123M vs $118M market cap).
- •Both run net losses; SPRB's is the smaller (0.00% vs -548.64% net margin).
Metrics side by side
Valuation
| Metric | SPRB | TNXP |
|---|---|---|
| P/S ratio | N/A | 4.21 |
| P/B ratio | 1.41 | 0.55 |
Profitability
| Metric | SPRB | TNXP |
|---|---|---|
| Gross margin | 0.00% | 34.65% |
| Operating margin | 0.00% | -959.05% |
| Net margin | 0.00% | -548.64% |
| ROE | -61.33% | -71.83% |
| ROIC | -50.67% | -74.08% |
Growth (annualized)
| Metric | SPRB | TNXP |
|---|---|---|
| Total return CAGR (5Y) | -36.23% | -87.55% |
Frequently asked
- How have SPRB and TNXP total returns compared?
- Over the past 5 years, SPRB delivered -36.23% and TNXP delivered -87.55% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.